It’s almost December, and that means it’s time for the ASH 2019 Annual Meeting. This is the world’s premier event in malignant & non-malignant hematology, and this year, it’s in sunny Orlando.
Immunotherapy treatments in hematology are a hot topic, and Medelis has guided many sponsors through the added complexities of these types of studies. Medelis has been a pioneer in immunotherapy treatments since 2008.
Connect with us now or at the show to say hello! Contact us or email our team directly to schedule:
This year’s annual meeting starts Saturday, December 7 and runs through Tuesday, December 10. Here are the abstracts.
The ASH 2019 Annual Meeting is a great way to network with top minds in the field, as well as a global community of more than 25,000 hematology professionals from every subspecialty.
If you’re attending, we’d enjoy meeting for a quick hello. Medelis has recently managed a number of complex hematology studies. We’d be happy to learn more about your platform and share how we overcome the complexities of finding the right site mix and patient population to prevent hematology studies from getting off track.
Contact us to learn more.
We hope to see you there!